Pharmaceutical Research

, Volume 26, Issue 10, pp 2324–2331 | Cite as

Pharmacokinetics and Pharmacodynamics of Broccoli Sprouts on the Suppression of Prostate Cancer in Transgenic Adenocarcinoma of Mouse Prostate (TRAMP) Mice: Implication of Induction of Nrf2, HO-1 and Apoptosis and the Suppression of Akt-dependent Kinase Pathway

  • Young-Sam Keum
  • Tin Oo Khor
  • Wen Lin
  • Guoxiang Shen
  • Ki Han Kwon
  • Avantika Barve
  • Wenge Li
  • Ah-Ng KongEmail author
Research Paper



In the present study, we have evaluated the pharmacokinetics and the in vivo prostate chemopreventive activity of broccoli sprouts.


The in vivo pharmacokinetic profiles of sulforaphane (SFN) and SFN- glutathione (GSH) conjugate in rats after oral administration of 200 mg and 500 mg broccoli sprouts were analyzed. Next, 8-week old TRAMP mice were fed with dietary broccoli sprouts at two dosages (60 and 240 mg/mouse/day) for 16 weeks, and the mice were sacrificed to examine the pharmacodynamic response on prostate tumor and some biomarkers.


SFN was readily released and conjugated with GSH in the rats after oral administration of broccoli sprouts. TRAMP mice fed with 240 mg broccoli sprouts/mouse/day exhibited a significant retardation of prostate tumor growth. Western blot analysis revealed that the expression levels of Nrf2, HO-1, cleaved-Caspase-3, cleaved-PARP and Bax proteins were increased, but that of Keap1 and Bcl-XL proteins were decreased. In addition, the phosphorylation and/or the expression level of Akt and its downstream kinase and target proteins, e.g. mTOR, 4E-BP1 and cyclin D1, were reduced.


Our findings indicate that broccoli sprouts can serve as a good dietary source of SFN in vivo and that they have significant inhibitory effects on prostate tumorigenesis.

Key words

broccoli sprout Nrf2 prostate cancer sulforaphane TRAMP mice 



We thank Mr. Richard Jarrell for providing us with the broccoli sprouts. We thank all the members in Dr. Ah-Ng “Tony” Kong’s lab for the help in discussion and preparation of this manuscript. This work was supported in part by the National Institute of Health Grant R01-CA118947 and Institutional Funds.


  1. 1.
    Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med. 2004;10:789–99.PubMedCrossRefGoogle Scholar
  2. 2.
    Eastham JA. Prostate-specific antigen doubling time as a prognostic marker in prostate cancer. Nat Clin Pract Urol. 2005;2:482–91.PubMedCrossRefGoogle Scholar
  3. 3.
    Klein EA. Can prostate cancer be prevented? Nat Clin Pract Urol. 2005;2:24–31.PubMedCrossRefGoogle Scholar
  4. 4.
    Goetzland MA, Holzbeierlein JM. Finasteride as a chemopreventive agent in prostate cancer: impact of the PCPT on urologic practice. Nat Clin Pract Urol. 2006;3:422–9.CrossRefGoogle Scholar
  5. 5.
    Kristaland AR, Lampe JW. Brassica vegetables and prostate cancer risk: a review of the epidemiological evidence. Nutr Cancer. 2002;42:1–9.CrossRefGoogle Scholar
  6. 6.
    Zhang Y. Cancer-preventive isothiocyanates: measurement of human exposure and mechanism of action. Mutat Res. 2004;555:173–90.PubMedGoogle Scholar
  7. 7.
    Zhang Y, Talalay P, Cho CG, Posner GH. A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc Natl Acad Sci U S A. 1992;89:2399–403.PubMedCrossRefGoogle Scholar
  8. 8.
    Keum YS, Jeong WS, Kong AN. Chemoprevention by isothiocyanates and their underlying molecular signaling mechanisms. Mutat Res. 2004;555:191–202.PubMedGoogle Scholar
  9. 9.
    Myzakand MC, Dashwood RH. Histone deacetylases as targets for dietary cancer preventive agents: lessons learned with butyrate, diallyl disulfide, and sulforaphane. Curr Drug Targets. 2006;7:443–52.CrossRefGoogle Scholar
  10. 10.
    Fahey JW, Zhang Y, Talalay P. Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc Natl Acad Sci U S A. 1997;94:10367–72.PubMedCrossRefGoogle Scholar
  11. 11.
    Kensler TW, Chen JG, Egner PA, Fahey JW, Jacobson LP, Stephenson KK, et al. Effects of glucosinolate-rich broccoli sprouts on urinary levels of aflatoxin-DNA adducts and phenanthrene tetraols in a randomized clinical trial in He Zuo township, Qidong People's Republic of China. Cancer Epidemiol Biomarkers Prev. 2005;14:2605–13.PubMedCrossRefGoogle Scholar
  12. 12.
    Tian Q, Rosselot RA, Schwartz SJ. Quantitative determination of intact glucosinolates in broccoli, broccoli sprouts, Brussels sprouts, and cauliflower by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry. Anal Biochem. 2005;343:93–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Barve A, Khor TO, Nair S, Reuhl K, Suh N, Reddy B, et al. Gamma-tocopherol-enriched mixed tocopherol diet inhibits prostate carcinogenesis in TRAMP mice. Int J Cancer. 2009;124:1693–9.PubMedCrossRefGoogle Scholar
  14. 14.
    Barve A, Khor TO, Hao X, Keum YS, Yang CS, Reddy B, et al. Murine prostate cancer inhibition by dietary phytochemicals—curcumin and phenyethylisothiocyanate. Pharm Res. 2008;25:2181–9.PubMedCrossRefGoogle Scholar
  15. 15.
    Greenberg NM, DeMayo FJ, Sheppard PC, Barrios R, Lebovitz R, Finegold M, et al. The rat probasin gene promoter directs hormonally and developmentally regulated expression of a heterologous gene specifically to the prostate in transgenic mice. Mol Endocrinol. 1994;8:230–9.PubMedCrossRefGoogle Scholar
  16. 16.
    T.W. Kensler, N. Wakabayashi, and S. Biswal. Cell Survival Responses to Environmental Stresses Via the Keap1-Nrf2-ARE Pathway. Annu Rev Pharmacol Toxicol (2006).Google Scholar
  17. 17.
    Jeong WS, Jun M, Kong AN. Nrf2: a potential molecular target for cancer chemoprevention by natural compounds. Antioxid Redox Signal. 2006;8:99–106.PubMedCrossRefGoogle Scholar
  18. 18.
    Shen G, Jeong WS, Hu R, Kong AN. Regulation of Nrf2, NF-kappaB, and AP-1 signaling pathways by chemopreventive agents. Antioxid Redox Signal. 2005;7:1648–63.PubMedCrossRefGoogle Scholar
  19. 19.
    Hanahanand D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57–70.CrossRefGoogle Scholar
  20. 20.
    Danialand NN, Korsmeyer SJ. Cell death: critical control points. Cell. 2004;116:205–19.CrossRefGoogle Scholar
  21. 21.
    Mamane Y, Petroulakis E, LeBacquer O, Sonenberg N. mTOR, translation initiation and cancer. Oncogene. 2006;25:6416–22.PubMedCrossRefGoogle Scholar
  22. 22.
    Sabatini DM. mTOR and cancer: insights into a complex relationship. Nat Rev Cancer. 2006;6:729–34.PubMedCrossRefGoogle Scholar
  23. 23.
    Diehl JA, Cheng M, Roussel MF, Sherr CJ. Glycogen synthase kinase- 3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 1998;12:3499–511.PubMedCrossRefGoogle Scholar
  24. 24.
    West LG, Meyer KA, Balch BA, Rossi FJ, Schultz MR, Haas GW. Glucoraphanin and 4-hydroxyglucobrassicin contents in seeds of 59 cultivars of broccoli, raab, kohlrabi, radish, cauliflower, brussels sprouts, kale, and cabbage. J Agric Food Chem. 2004;52:916–26.PubMedCrossRefGoogle Scholar
  25. 25.
    Shen G, Khor TO, Hu R, Yu S, Nair S, Ho CT, et al. Chemoprevention of familial adenomatous polyposis by natural dietary compounds sulforaphane and dibenzoylmethane alone and in combination in ApcMin/+ mouse. Cancer Res. 2007;67:9937–44.PubMedCrossRefGoogle Scholar
  26. 26.
    Lamband DJ, Zhang L. Challenges in prostate cancer research: animal models for nutritional studies of chemoprevention and disease progression. J Nutr. 2005;135:3009S–15.Google Scholar
  27. 27.
    Klein RD. The use of genetically engineered mouse models of prostate cancer for nutrition and cancer chemoprevention research. Mutat Res. 2005;576:111–19.PubMedGoogle Scholar
  28. 28.
    Adhami VM, Siddiqui IA, Ahmad N, Gupta S, Mukhtar H. Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I- induced signaling in an autochthonous mouse model of prostate cancer. Cancer Res. 2004;64:8715–22.PubMedCrossRefGoogle Scholar
  29. 29.
    Narayanan BA, Narayanan NK, Pittman B, Reddy BS. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model. Clin Cancer Res. 2004;10:7727–37.PubMedCrossRefGoogle Scholar
  30. 30.
    Gupta S, Adhami VM, Subbarayan M, MacLennan GT, Lewin JS, Hafeli UO, et al. Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model. Cancer Res. 2004;64:3334–43.PubMedCrossRefGoogle Scholar
  31. 31.
    Garcia GE, Wisniewski HG, Lucia MS, Arevalo N, Slaga TJ, Kraft SL, et al. 2-Methoxyestradiol inhibits prostate tumor development in transgenic adenocarcinoma of mouse prostate: role of tumor necrosis factor-alpha-stimulated gene 6. Clin Cancer Res. 2006;12:980–8.PubMedCrossRefGoogle Scholar
  32. 32.
    Raina K, Blouin MJ, Singh RP, Majeed N, Deep G, Varghese L, et al. Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model. Cancer Res. 2007;67:11083–91.PubMedCrossRefGoogle Scholar
  33. 33.
    Singh SV, Warin R, Xiao D, Powolny AA, Stan SD, Arlotti JA, et al. Sulforaphane inhibits prostate carcinogenesis and pulmonary metastasis in TRAMP mice in association with increased cytotoxicity of natural killer cells. Cancer Res. 2009;69:2117–25.PubMedCrossRefGoogle Scholar
  34. 34.
    Xiao D, Zeng Y, Choi S, Lew KL, Nelson JB, Singh SV. Caspase- dependent apoptosis induction by phenethyl isothiocyanate, a cruciferous vegetable-derived cancer chemopreventive agent, is mediated by Bak and Bax. Clin Cancer Res. 2005;11:2670–9.PubMedCrossRefGoogle Scholar
  35. 35.
    Singh SV, Warin R, Xiao D, Powolny AA, Stan SD, Arlotti JA, et al. Sulforaphane inhibits prostate carcinogenesis and pulmonary metastasis in TRAMP mice in association with increased cytotoxicity of natural killer cells. Cancer Res. 2009;69:2117–25. Epub 2009 Feb 2117.PubMedCrossRefGoogle Scholar
  36. 36.
    Chen ML, Xu PZ, Peng XD, Chen WS, Guzman G, Yang X, et al. The deficiency of Akt1 is sufficient to suppress tumor development in Pten+/− mice. Genes Dev. 2006;20:1569–74.PubMedCrossRefGoogle Scholar
  37. 37.
    Trotman LC, Alimonti A, Scaglioni PP, Koutcher JA, Cordon-Cardo C, Pandolfi PP. Identification of a tumour suppressor network opposing nuclear Akt function. Nature. 2006;441:523–7.PubMedCrossRefGoogle Scholar
  38. 38.
    Gao H, Ouyang X, Banach-Petrosky WA, Gerald WL, Shen MM, Abate-Shen C. Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer. Proc Natl Acad Sci U S A. 2006;103:14477–82.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Young-Sam Keum
    • 1
  • Tin Oo Khor
    • 1
  • Wen Lin
    • 1
    • 2
  • Guoxiang Shen
    • 1
    • 3
  • Ki Han Kwon
    • 1
  • Avantika Barve
    • 1
    • 4
  • Wenge Li
    • 1
  • Ah-Ng Kong
    • 1
    Email author
  1. 1.Department of Pharmaceutics and Ernest Mario School of PharmacyRutgers The State University of New JerseyPiscatawayUSA
  2. 2.Novartis Institutes for BioMedical Research, DMPK-Translational Sciences (TS)East HanoverUSA
  3. 3.Metabolism and Pharmacokinetics, Research & Development Bristol- Myers Squibb CoPrincetonUSA
  4. 4.Bioanalytical R & D, Wyeth PharmaceuticalsPearl RiverUSA

Personalised recommendations